HeartX Accelerator Names 5 Startups for 2023 Program
Each company will receive $150,000 of investment capital, along with access to clinicians and administrators while executing their pilot projects and clinical studies.
Stay updated with breaking news from Extended Holter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Each company will receive $150,000 of investment capital, along with access to clinicians and administrators while executing their pilot projects and clinical studies.
BENTONVILLE, Ark., October 16, 2023--HeartX, powered by HealthTech Arkansas and MedAxiom along with eleven leading cardiology practices in Arkansas and around the country — has selected the five startup healthcare companies that will participate in the 2023 accelerator program. HeartX is a cardiovascular-focused healthcare accelerator that facilitates guaranteed hospital pilot projects and clinical trials for accomplished, early-stage companies bringing new cardiovascular innovations to market.
InfoBionic, the virtual telemetry company focused on efficiency and economics of cardiac remote patient monitoring, announces FDA 510(k) clearance for its MoMe ARC solution that encompasses our next generation remote ECG monitoring device and initial Bluetooth diagnostic 6-lead sensor designed to aid physicians in their diagnosis of cardiac arrhythmias.
Prime Hospital offers a range of heart screening tests
G Medical Innovations Holdings Ltd. Announces its ordinary shares and warrants to be quoted on the over-the-counter pink under the trading symbols GMVDF and GMVWF; Company...